A recent review article in Nature Reviews Neurology highlights the pressing global and regional burden of diabetic peripheral neuropathy (DPN), a condition that affects up to 50% of people with type 1 or type 2 diabetes. The article, authored by Savelieff et al., not only underscores the profound individual and socioeconomic toll of DPN but also calls... Continue Reading →